SMTL ID : 5jt2.1 (1 other biounit)

BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

homo-dimer

Ligands

2 x BEN: BENZAMIDINE(Non-functional Binders)

BEN.1: 7 residues within 4Å: Chain A: D.6, W.7, E.8, I.9, P.10, M.74, G.75 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:I.9 Hydrogen bonds: A:M.74 pi-Stacking: A:W.33 BEN.3: 5 residues within 4Å: Chain B: W.7, R.66, L.72, F.73, M.74 3 PLIP interactions: 3 interactions with chain B Hydrophobic interactions: B:W.7, B:W.7 Hydrogen bonds: B:M.74

1 x 6NC: 2,2'-oxybis(N-{[4-(3-{2,6-difluoro-3-[(propane-1-sulfonyl)amino]benzoyl}-1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]methyl}acetamide)(Non-covalent)

6NC.2: 45 residues within 4Å: Chain A: Q.18, I.20, V.28, A.38, V.39, K.40, L.62, L.71, L.72, F.73, I.84, T.86, Q.87, W.88, C.89, S.92, S.93, H.96, F.140, G.150, D.151, F.152, G.153 Chain B: I.20, V.28, A.38, V.39, K.40, L.62, L.71, L.72, F.73, I.84, T.86, Q.87, W.88, C.89, S.92, S.93, H.96, F.140, G.150, D.151, F.152, G.153 41 PLIP interactions: 20 interactions with chain B, 21 interactions with chain A Hydrophobic interactions: B:I.20, B:A.38, B:K.40, B:L.62, B:L.71, B:L.71, B:F.73, B:T.86, B:W.88, B:F.140, B:F.140, B:F.152, A:I.20, A:A.38, A:K.40, A:L.62, A:F.73, A:T.86, A:T.86, A:W.88, A:F.140, A:F.152 Hydrogen bonds: B:K.40, B:T.86, B:Q.87, B:C.89, B:D.151, B:D.151, B:F.152, B:G.153, A:Q.18, A:K.40, A:T.86, A:Q.87, A:C.89, A:D.151, A:D.151, A:F.152, A:G.153 pi-Stacking: A:F.140, A:F.140

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Grasso, M. et al., Chemically Linked Vemurafenib Inhibitors Promote an Inactive BRAF(V600E) Conformation. Acs Chem.Biol. (2016)

Release Date

2016-09-14

Peptides

Serine/threonine-protein kinase B-raf: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Serine/threonine-protein kinase B-raf

Related Entries With Identical Sequence